Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate.
Lukas NiererChukwuka EzeVanessa da Silva MendesJuliane BraunPatrick ThumRieke von BestenbostelChristopher KurzGuillaume LandryMichael ReinerMaximilian NiyaziClaus BelkaStefanie CorradiniPublished in: Radiation oncology (London, England) (2022)
With online plan adaptation, it was possible to achieve significant improvements in target volume coverage and OAR sparing for various tumor entities and account for interfractional anatomical changes.